EstechPharma Co. Ltd Cash Flow-to-Debt Ratio
EstechPharma Co. Ltd cash flow-to-debt ratio. EstechPharma Co. Ltd (041910) has a Cash Flow-to-Debt Ratio of 0.04x as of December 2025, meaning its operating cash flow of ₩2.38 Billion could theoretically repay 0% of its total liabilities (₩60.00 Billion) in one year. Check how high is EstechPharma Co. Ltd's earnings quality to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of EstechPharma Co. Ltd (2013–2025)
Cash flow-to-debt ratio of EstechPharma Co. Ltd from 2013 to 2025. Historical debt coverage capacity for EstechPharma Co. Ltd across 13 annual periods. Check EstechPharma Co. Ltd investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
EstechPharma Co. Ltd Cash Flow-to-Debt Ratio by Year (2013–2025)
EstechPharma Co. Ltd cash flow-to-debt ratio by year from 2013 to 2025. Year-by-year debt coverage analysis for EstechPharma Co. Ltd. For the full cash flow conversion analysis, see EstechPharma Co. Ltd cash conversion from operations.
| Year | CF-to-Debt Ratio | Operating CF (KRW) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.15x | ₩8.83 Billion | ₩60.00 Billion | ▼ -89.1% |
| 2024 | 1.35x | ₩7.93 Billion | ₩5.87 Billion | ▲ +76.9% |
| 2023 | 0.76x | ₩4.79 Billion | ₩6.27 Billion | ▲ +481.2% |
| 2022 | -0.20x | ₩-1.65 Billion | ₩8.23 Billion | ▼ -467.5% |
| 2021 | 0.05x | ₩603.42 Million | ₩11.06 Billion | ▼ -86.4% |
| 2020 | 0.40x | ₩4.71 Billion | ₩11.76 Billion | ▲ +28.0% |
| 2019 | 0.31x | ₩4.29 Billion | ₩13.71 Billion | ▼ -60.7% |
| 2018 | 0.80x | ₩7.25 Billion | ₩9.09 Billion | ▲ +43.4% |
| 2017 | 0.56x | ₩6.99 Billion | ₩12.57 Billion | ▲ +36.2% |
| 2016 | 0.41x | ₩8.19 Billion | ₩20.05 Billion | ▼ -24.9% |
| 2015 | 0.54x | ₩10.46 Billion | ₩19.24 Billion | ▲ +320.0% |
| 2014 | 0.13x | ₩4.99 Billion | ₩38.57 Billion | ▼ -53.7% |
| 2013 | 0.28x | ₩10.19 Billion | ₩36.41 Billion | — |